Valuation for Nykode Therapeutics AS (id:10313 NYKD)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | -25.00 |
|
|
| Forward P/E | -18.19 |
|
|
| Price to sales | 145.83 |
|
|
| Price to book | 5.55 |
|
|
| Enterprise to revenue | 121.60 |
|
|
| Enterprise to ebitda | -13.63 |
|
|